ReviewFrontiers in oncology2019

Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets.

Esma Saada-Bouzid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.